CN103356427B - 剥离型红景天滋养面膜及其制备方法 - Google Patents
剥离型红景天滋养面膜及其制备方法 Download PDFInfo
- Publication number
- CN103356427B CN103356427B CN201310200446.4A CN201310200446A CN103356427B CN 103356427 B CN103356427 B CN 103356427B CN 201310200446 A CN201310200446 A CN 201310200446A CN 103356427 B CN103356427 B CN 103356427B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix rhodiolae
- facial film
- skin
- rhodiola rosea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000001815 facial effect Effects 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 244000042430 Rhodiola rosea Species 0.000 title abstract description 6
- 235000003713 Rhodiola rosea Nutrition 0.000 title abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 28
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 25
- QRYRORQUOLYVBU-VBKZILBWSA-N carnosic acid Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims abstract description 22
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 claims abstract description 15
- 108010053775 Nisin Proteins 0.000 claims abstract description 15
- 239000004309 nisin Substances 0.000 claims abstract description 15
- 235000010297 nisin Nutrition 0.000 claims abstract description 15
- 239000003755 preservative agent Substances 0.000 claims abstract description 12
- 230000002335 preservative effect Effects 0.000 claims abstract description 12
- 102000016942 Elastin Human genes 0.000 claims abstract description 11
- 108010014258 Elastin Proteins 0.000 claims abstract description 11
- 150000001875 compounds Chemical class 0.000 claims abstract description 11
- 229920002549 elastin Polymers 0.000 claims abstract description 11
- 239000004372 Polyvinyl alcohol Substances 0.000 claims abstract description 9
- 239000004006 olive oil Substances 0.000 claims abstract description 9
- 235000008390 olive oil Nutrition 0.000 claims abstract description 9
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000011734 sodium Substances 0.000 claims abstract description 8
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 8
- 239000008367 deionised water Substances 0.000 claims abstract description 7
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 7
- 238000007796 conventional method Methods 0.000 claims abstract description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 14
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 14
- 239000011630 iodine Substances 0.000 claims description 14
- 229910052740 iodine Inorganic materials 0.000 claims description 14
- KRPAJLYSLFNDOA-UHFFFAOYSA-N mephenesin carbamate Chemical compound CC1=CC=CC=C1OCC(O)COC(N)=O KRPAJLYSLFNDOA-UHFFFAOYSA-N 0.000 claims description 14
- 229950006838 mephenesin carbamate Drugs 0.000 claims description 14
- 230000007062 hydrolysis Effects 0.000 claims description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 6
- 239000003643 water by type Substances 0.000 claims description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 2
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 abstract description 7
- 235000011187 glycerol Nutrition 0.000 abstract description 7
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract description 3
- 235000017491 Bambusa tulda Nutrition 0.000 abstract description 3
- 244000082204 Phyllostachys viridis Species 0.000 abstract description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract description 3
- 239000003963 antioxidant agent Substances 0.000 abstract description 3
- 239000011425 bamboo Substances 0.000 abstract description 3
- 239000008280 blood Substances 0.000 abstract description 3
- 238000004140 cleaning Methods 0.000 abstract description 3
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000037303 wrinkles Effects 0.000 abstract description 2
- 150000007942 carboxylates Chemical class 0.000 abstract 1
- 239000010408 film Substances 0.000 description 42
- 210000003491 skin Anatomy 0.000 description 38
- 230000000052 comparative effect Effects 0.000 description 29
- 230000002421 anti-septic effect Effects 0.000 description 22
- 239000002537 cosmetic Substances 0.000 description 12
- WPTUPLITBGLORN-VOTSOKGWSA-N 2-amino-4-oxo-6-[(e)-2-phenylethenyl]-1,7-dihydropyrrolo[2,3-d]pyrimidine-5-carbonitrile Chemical compound N#CC=1C=2C(=O)NC(N)=NC=2NC=1\C=C\C1=CC=CC=C1 WPTUPLITBGLORN-VOTSOKGWSA-N 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 239000000284 extract Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 244000005700 microbiome Species 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 6
- 230000035943 smell Effects 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 5
- 150000001735 carboxylic acids Chemical class 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 210000002615 epidermis Anatomy 0.000 description 5
- IEBFEMIXXHIISM-UHFFFAOYSA-N rozarin Natural products OC1C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC=CC=2C=CC=CC=2)O1 IEBFEMIXXHIISM-UHFFFAOYSA-N 0.000 description 5
- RINHYCZCUGCZAJ-UHFFFAOYSA-N rozavin Natural products OC1C(O)C(O)COC1OCC1C(O)C(O)C(O)C(OCC=CC=2C=CC=CC=2)O1 RINHYCZCUGCZAJ-UHFFFAOYSA-N 0.000 description 5
- RINHYCZCUGCZAJ-IPXOVKFZSA-N Rosavin Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)CO[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC\C=C\C=2C=CC=CC=2)O1 RINHYCZCUGCZAJ-IPXOVKFZSA-N 0.000 description 4
- ILRCGYURZSFMEG-RKQHYHRCSA-N Salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RKQHYHRCSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000004567 concrete Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000000822 natural killer cell Anatomy 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- JJYVNURTNGHITH-UHFFFAOYSA-N rosavin Natural products OC1COC(OCC2OC(OC(=O)C=Cc3ccccc3)C(O)C(O)C2O)C(O)C1O JJYVNURTNGHITH-UHFFFAOYSA-N 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 229940076279 serotonin Drugs 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 2
- 206010054089 Depressive symptom Diseases 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000745988 Phyllostachys Species 0.000 description 2
- IEBFEMIXXHIISM-YZOUKVLTSA-N Rosarin Chemical compound O[C@@H]1[C@@H](O)[C@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC\C=C\C=2C=CC=CC=2)O1 IEBFEMIXXHIISM-YZOUKVLTSA-N 0.000 description 2
- IEBFEMIXXHIISM-XZDFAHJYSA-N Rosarin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO[C@H]2[C@@H](O)[C@@H](O)[C@@H](CO)O2)O1 IEBFEMIXXHIISM-XZDFAHJYSA-N 0.000 description 2
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 2
- 229960001083 diazolidinylurea Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 125000004344 phenylpropyl group Chemical class 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- POVCYOFRCMBMKD-XMSQKQJNSA-N (2r,3r)-6,8-dihydroxy-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-9-(4-hydroxyphenyl)-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-7-one Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=C4C(C(C(O)=C(O4)C=4C=CC(O)=CC=4)=O)=C(O)C=C3O2)CO)=C1 POVCYOFRCMBMKD-XMSQKQJNSA-N 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 244000139693 Arctostaphylos uva ursi Species 0.000 description 1
- 235000012871 Arctostaphylos uva ursi Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000220284 Crassulaceae Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- QEVGZEDELICMKH-UHFFFAOYSA-N Diglycolic acid Chemical compound OC(=O)COCC(O)=O QEVGZEDELICMKH-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- DPUYCSDGMSDKKV-MKBYFEBXSA-N N-Acetyl-L-leucyl-L-isoleucylglycyl-L-valyl-N-methyl-L-prolinamide Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC DPUYCSDGMSDKKV-MKBYFEBXSA-N 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000997135 Rhodiola crenulata Species 0.000 description 1
- 241001529742 Rosmarinus Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Chemical class 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000019261 food antioxidant Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 150000002338 glycosides Chemical group 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- 229940091173 hydantoin Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- POVCYOFRCMBMKD-UHFFFAOYSA-N rhodiolinin Natural products C1=C(O)C(OC)=CC(C2C(OC3=C4C(C(C(O)=C(O4)C=4C=CC(O)=CC=4)=O)=C(O)C=C3O2)CO)=C1 POVCYOFRCMBMKD-UHFFFAOYSA-N 0.000 description 1
- 235000015639 rosmarinus officinalis Nutrition 0.000 description 1
- 230000001835 salubrious effect Effects 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 208000012672 seasonal affective disease Diseases 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 239000010463 virgin olive oil Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
实施例1 | 对比例1 | 对比例2 | 对比例3 | 对比例4 | 对比例5 | |
去离子水 | 100 | 100 | 100 | 100 | 100 | 100 |
聚乙烯醇PVA2488 | 12 | 12 | 12 | 12 | 12 | 12 |
甘油 | 10 | 10 | 10 | 10 | 10 | 10 |
水解弹性蛋白 | 1 | 1 | 1 | 1 | 1 | 1 |
乙醇 | 5 | 5 | 5 | 5 | 5 | 5 |
PEG-8橄榄油羧酸钠 | 7 | 7 | 7 | 7 | 7 | 7 |
红景天提取液 | 1 | 1 | 1 | 1 | 1 | 1 |
鼠尾草酸 | 0.01 | / | / | / | / | / |
竹叶抗氧化物 | 0.02 | 0.02 | 0.02 | 0.03 | / | / |
乳酸链球菌素 | 0.01 | 0.01 | 0.02 | 0.01 | / | / |
碘丙炔醇丁基氨甲酸酯 | 0.01 | 0.02 | 0.01 | 0.01 | / | / |
对羟基苯甲酸甲酯 | / | / | / | / | 0.05 | / |
观察现象 | |
实施例1 | 60天后未见异常,气味纯正 |
对比例1 | 50天后,出现霉斑,微生物超标,散发出不愉快气味 |
对比例2 | 40天后,出现霉斑,微生物超标,散发出不愉快气味 |
对比例3 | 40天后,出现霉斑,微生物超标,散发出不愉快气味 |
对比例4 | 40天后,出现霉斑,微生物超标,散发出不愉快气味 |
对比例5 | 5天后,出现霉斑,微生物超标,散发出不愉快气味 |
使用前,au | 使用后,au | 使用后1小时,au | |
实施例1 | 37.9 | 79.4 | 74.2 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310200446.4A CN103356427B (zh) | 2013-05-26 | 2013-05-26 | 剥离型红景天滋养面膜及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310200446.4A CN103356427B (zh) | 2013-05-26 | 2013-05-26 | 剥离型红景天滋养面膜及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103356427A CN103356427A (zh) | 2013-10-23 |
CN103356427B true CN103356427B (zh) | 2015-04-29 |
Family
ID=49359255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310200446.4A Expired - Fee Related CN103356427B (zh) | 2013-05-26 | 2013-05-26 | 剥离型红景天滋养面膜及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103356427B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103751044B (zh) * | 2013-11-26 | 2015-12-30 | 广州千百度化妆品有限公司 | 一种瘦脸紧致提升的面膜 |
CN105832616A (zh) * | 2016-05-20 | 2016-08-10 | 郑凯峰 | 温泉密集补水嫩肤面膜及其制备方法 |
CH714725B1 (de) * | 2018-03-06 | 2023-05-15 | Perfect Ideas Gmbh | Reinigungs- und Pflegezubereitungen. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1506108A (zh) * | 2002-12-09 | 2004-06-23 | 戚海燕 | 一种食用又能化妆美容面膜的奶粉复合粉 |
CN102198062B (zh) * | 2011-05-26 | 2012-09-19 | 成都中医药大学 | 一种丹参面膜及其制备方法 |
-
2013
- 2013-05-26 CN CN201310200446.4A patent/CN103356427B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN103356427A (zh) | 2013-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103356420B (zh) | 剥离型薏苡仁面膜及其制备方法 | |
CN103356425B (zh) | 剥离型人参面膜及其制备方法 | |
CN103356427B (zh) | 剥离型红景天滋养面膜及其制备方法 | |
CN103385826B (zh) | 剥离型绿豆祛痘面膜及其制备方法 | |
CN103385824B (zh) | 剥离型丹参面膜及其制备方法 | |
CN103405358B (zh) | 剥离型樱桃紧肤面膜及其制备方法 | |
CN103356471B (zh) | 剥离型三七面膜及其制备方法 | |
CN103356472B (zh) | 剥离型金龙胆草面膜及其制备方法 | |
CN103385840B (zh) | 剥离型燕窝润肤面膜及其制备方法 | |
CN103356464B (zh) | 剥离型黄芩洁肤面膜及其制备方法 | |
CN103356469B (zh) | 剥离型红石榴面膜及其制备方法 | |
CN103385847B (zh) | 剥离型苹果淡斑面膜及其制备方法 | |
CN103356433B (zh) | 剥离型绿茶润肤面膜及其制备方法 | |
CN103356429B (zh) | 剥离型甘草杀菌面膜及其制备方法 | |
CN103356473B (zh) | 剥离型薰衣草焕肤面膜及其制备方法 | |
CN103356434B (zh) | 剥离型白术面膜及其制备方法 | |
CN103356422B (zh) | 剥离型矢车菊面膜及其制备方法 | |
CN103356470B (zh) | 剥离型蒲公英洁肤面膜及其制备方法 | |
CN103356435B (zh) | 剥离型银杏净白面膜及其制备方法 | |
CN103356467B (zh) | 剥离型灵芝面膜及其制备方法 | |
CN103356423B (zh) | 剥离型茯苓面膜及其制备方法 | |
CN103356421B (zh) | 剥离型三色菫面膜及其制备方法 | |
CN103356405B (zh) | 剥离型褐藻营养面膜及其制备方法 | |
CN103356426B (zh) | 剥离型地榆杀菌面膜及其制备方法 | |
CN103385825B (zh) | 剥离型黄橙净白面膜及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: MA JIANXIN Free format text: FORMER OWNER: SHANGHAI ZHENXIN CHEMICAL TECHNOLOGY CO., LTD. Effective date: 20150324 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Ma Jianxin Inventor before: Wang Feifen |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG FEIFEN TO: MA JIANXIN Free format text: CORRECT: ADDRESS; FROM: 201111 MINHANG, SHANGHAI TO: 830000 URUMQI, XINJIANG UYGUR AUTONOMOUS REGION |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150324 Address after: 830000 No. 5, building 4, No. 174, north shore road, Shuimogou District, the Xinjiang Uygur Autonomous Region, Urumqi, 302 Applicant after: Ma Jianxin Address before: Room 2118 building four layer d441 No. third Shanghai 201111 Minhang District Guanghua Road Applicant before: Shanghai Zhenxin Chemical Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150429 Termination date: 20170526 |